Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael T Tetzlaff

Showing results (81-90 of 224) with videos related to

Pageof 23
Sort By:
The American Journal of Dermatopathology|August 30, 2019
Measurement of Tumor Thickness in Cutaneous Squamous Cell Carcinomas: Do the Different Methods Provide Better Prognostic Data?Pelin Yildiz, Phyu P Aung, Denái R Milton, et al.
Annals of Diagnostic Pathology|November 2, 2019
Unusual cutaneous metastatic carcinomaSory J Ruiz, Suhair Al Salihi, Victor G Prieto, et al.
Cancer Immunology Research|April 19, 2019
IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from ImmunotherapyDaniel Johnson, Anisha B Patel, Marc I Uemura, et al.
Molecular Cancer Therapeutics|October 7, 2015
Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and SequencingJeannelyn S Estrella, Michael T Tetzlaff, Roland L Bassett, et al.
Journal of Cutaneous Pathology|September 30, 2014
Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinomaSamuel A Henderson, Michael T Tetzlaff, Penvadee Pattanaprichakul, et al.
Oncoimmunology|September 20, 2018
High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinomaThomas J Kandl, Oded Sagiv, Jonathan L Curry, et al.
Cancer Research|July 21, 2018
Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow-Resident Melanoma CTCsMonika Vishnoi, Debasish Boral, Haowen Liu, et al.
Human Pathology|September 27, 2016
Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanomaAlan E Siroy, Phyu P Aung, Carlos A Torres-Cabala, et al.
The American Journal of Surgical Pathology|September 25, 2013
Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analysesMichael T Tetzlaff, Wei-Lien Wang, Tiffani L Milless, et al.
Cancer|March 3, 2015
Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registriesIvan V Litvinov, Michael T Tetzlaff, Elham Rahme, et al.
Pageof 23

Showing results (81-90 of 224) with videos related to

Sort By:
Pageof 23
The American Journal of Dermatopathology|August 30, 2019
Measurement of Tumor Thickness in Cutaneous Squamous Cell Carcinomas: Do the Different Methods Provide Better Prognostic Data?Pelin Yildiz, Phyu P Aung, Denái R Milton, et al.
Annals of Diagnostic Pathology|November 2, 2019
Unusual cutaneous metastatic carcinomaSory J Ruiz, Suhair Al Salihi, Victor G Prieto, et al.
Cancer Immunology Research|April 19, 2019
IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from ImmunotherapyDaniel Johnson, Anisha B Patel, Marc I Uemura, et al.
Molecular Cancer Therapeutics|October 7, 2015
Assessment of BRAF V600E Status in Colorectal Carcinoma: Tissue-Specific Discordances between Immunohistochemistry and SequencingJeannelyn S Estrella, Michael T Tetzlaff, Roland L Bassett, et al.
Journal of Cutaneous Pathology|September 30, 2014
Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinomaSamuel A Henderson, Michael T Tetzlaff, Penvadee Pattanaprichakul, et al.
Oncoimmunology|September 20, 2018
High expression of PD-1 and PD-L1 in ocular adnexal sebaceous carcinomaThomas J Kandl, Oded Sagiv, Jonathan L Curry, et al.
Cancer Research|July 21, 2018
Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow-Resident Melanoma CTCsMonika Vishnoi, Debasish Boral, Haowen Liu, et al.
Human Pathology|September 27, 2016
Clinical significance of BRAF V600E mutational status in capsular nevi of sentinel lymph nodes in patients with primary cutaneous melanomaAlan E Siroy, Phyu P Aung, Carlos A Torres-Cabala, et al.
The American Journal of Surgical Pathology|September 25, 2013
Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analysesMichael T Tetzlaff, Wei-Lien Wang, Tiffani L Milless, et al.
Cancer|March 3, 2015
Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registriesIvan V Litvinov, Michael T Tetzlaff, Elham Rahme, et al.
Pageof 23